Ascendis Pharma A/S (ASND)
229.27
+4.27
(+1.90%)
USD |
NASDAQ |
Apr 24, 16:00
229.39
+0.12
(+0.05%)
After-Hours: 20:00
Ascendis Pharma Market Cap : 14.16B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 182.60B |
| Evaxion AS | 33.61M |
| Biodexa Pharmaceuticals Plc | 2.140M |
| Trinity Biotech Plc | 12.11M |
| DBV Technologies SA | 1.088B |
Market Cap Related Metrics
| PS Ratio | 16.89 |
| Price to Free Cash Flow | 263.27 |
| Price | 229.27 |
| Earnings Yield | -1.83% |